These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3420931)

  • 1. Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid.
    Ryan JJ; Hay ID; Grant CS; Rainwater LM; Farrow GM; Goellner JR
    World J Surg; 1988 Aug; 12(4):482-7. PubMed ID: 3420931
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA aneuploidy in follicular thyroid neoplasia.
    Cusick EL; Ewen SW; Krukowski ZH; Matheson NA
    Br J Surg; 1991 Jan; 78(1):94-6. PubMed ID: 1998875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of DNA flow cytometry in distinguishing between malignant and benign intrahepatic biliary lesions.
    Wen KW; Rabinovitch PS; Wang D; Mattis AN; Ferrell LD; Choi WT
    Virchows Arch; 2020 Oct; 477(4):527-534. PubMed ID: 32296928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
    Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
    Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms.
    Schelfhout LJ; Cornelisse CJ; Goslings BM; Hamming JF; Kuipers-Dijkshoorn NJ; van de Velde CJ; Fleuren GJ
    Int J Cancer; 1990 Jan; 45(1):16-20. PubMed ID: 2298499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
    Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
    Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer.
    Hamming JF; Schelfhout LJ; Cornelisse CJ; van de Velde CJ; Goslings BM; Hermans J; Fleuren GJ
    World J Surg; 1988 Aug; 12(4):503-8. PubMed ID: 3420932
    [No Abstract]   [Full Text] [Related]  

  • 8. [Flow cytometry of thyroid tumors. Study of fresh tissue in 50 patients].
    Suissa J; Hoang C; Soubrane C; Chigot JP; Khayat D; Leenhardt L; Aurengo A; Turpin G; Le Charpentier Y
    Presse Med; 1994 Feb; 23(4):159-63. PubMed ID: 8177857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid.
    Bronner MP; Clevenger CV; Edmonds PR; Lowell DM; McFarland MM; LiVolsi VA
    Am J Clin Pathol; 1988 Jun; 89(6):764-9. PubMed ID: 3369368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of flow cytometry with static densitometry in papillary thyroid carcinoma.
    Cusick EL; MacIntosh CA; Krukowski ZH; Ewen SW; Matheson NA
    Br J Surg; 1990 Aug; 77(8):913-6. PubMed ID: 2393818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Flow cytometric analysis of DNA aneuploidy in adrenal tumors].
    Itakura H; Kinoshita K; Munakata A; Takamoto S; Minowada S; Aso Y
    Nihon Hinyokika Gakkai Zasshi; 1992 Jan; 83(1):53-8. PubMed ID: 1564827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric measurements of nuclear DNA and ploidy analysis in Hürthle cell neoplasms of the thyroid.
    McLeod MK; Thompson NW; Hudson JL; Gaglio JA; Lloyd RV; Harness JK; Nishiyama R; Cheung PS
    Arch Surg; 1988 Jul; 123(7):849-54. PubMed ID: 3382350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of false DNA aneuploidy and false DNA multiploidy in flow cytometric DNA analysis.
    Zbieranowski I; Demianiuk C; Bell V; Knape WA; Murray D
    Anal Cell Pathol; 1993 Mar; 5(2):69-84. PubMed ID: 8466851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.
    Joensuu H; Ahonen A; Klemi PJ
    Eur J Nucl Med; 1988; 13(10):502-6. PubMed ID: 3371370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA cytophotometry of oxyphilic thyroid tumors].
    Pilch H; Back W; Winter J
    Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hürthle cell tumor of the thyroid gland. Analysis of a series of 33 cases].
    Janser JC; Pusel J; Rodier JF; Navarrete E; Rodier D
    J Chir (Paris); 1989 Nov; 126(11):619-24. PubMed ID: 2685000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12-year follow up.
    Lukács GL; Balázs G; Zs-Nagy I; Mikó T
    Eur J Surg; 1994 Aug; 160(8):417-23. PubMed ID: 7811827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of measurement of ras oncogenes and nuclear DNA analysis in the diagnosis of Hürthle cell tumors of the thyroid.
    Schark C; Fulton N; Yashiro T; Stanislav G; Jacoby R; Straus FH; Dytch H; Bibbo M; Kaplan EL
    World J Surg; 1992; 16(4):745-51; discussion 752. PubMed ID: 1413844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hürthle cell tumors of the thyroid. A flow cytometric DNA analysis.
    el-Naggar AK; Batsakis JG; Luna MA; Hickey RC
    Arch Otolaryngol Head Neck Surg; 1988 May; 114(5):520-1. PubMed ID: 3355687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hürthle cell adenoma of the thyroid in identical twins with 13 year follow-up.
    Nagamachi Y; Nakamura T; Yamada T
    Jpn J Surg; 1973 Dec; 3(4):212-7. PubMed ID: 4803038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.